Literature DB >> 28186722

Structure-Property Relations of Methylamine Vapor Treated Hybrid Perovskite CH3NH3PbI3 Films and Solar Cells.

Bert Conings1,2, Simon A Bretschneider3, Aslihan Babayigit1,2, Nicolas Gauquelin4, Ilaria Cardinaletti1, Jean Manca5, Jo Verbeeck4, Henry J Snaith2, Hans-Gerd Boyen1.   

Abstract

The power conversion efficiency of halide perovskite solar cells is heavily dependent on the perovskite layer being sufficiently smooth and pinhole-free. It has been shown that these features can be obtained even when starting out from rough and discontinuous perovskite film by briefly exposing the film to methylamine (MA) vapor. The exact underlying physical mechanisms of this phenomenon are, however, still unclear. By investigating smooth, MA treated films based on very rough and discontinuous reference films of methylammonium triiode (MAPbI3) and considering their morphology, crystalline features, local conductive properties, and charge carrier lifetime, we unraveled the relation between their characteristic physical qualities and their performance in corresponding solar cells. We discovered that the extensive improvement in photovoltaic performance upon MA treatment is a consequence of the induced morphological enhancement of the perovskite layer together with improved electron injection into TiO2, which in fact compensates for an otherwise compromised bulk electronic quality simultaneously caused by the MA treatment.

Entities:  

Keywords:  MAPbI3; crystalline quality; methylamine vapor; morphology; perovskite solar cells; power conversion efficiency

Year:  2017        PMID: 28186722     DOI: 10.1021/acsami.6b15175

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  1 in total

1.  Simultaneous heteroepitaxial growth of SrO (001) and SrO (111) during strontium-assisted deoxidation of the Si (001) surface.

Authors:  Zoran Jovanović; Nicolas Gauquelin; Gertjan Koster; Juan Rubio-Zuazo; Philippe Ghosez; Johan Verbeeck; Danilo Suvorov; Matjaž Spreitzer
Journal:  RSC Adv       Date:  2020-08-24       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.